STEMLINE THERAPEUTICS INC's ticker is STML and the CUSIP is 85858C107.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2020 | $182,000 | -28.3% | 37,646 | +57.3% | 0.00% | 0.0% |
Q4 2019 | $254,000 | -33.9% | 23,929 | -19.9% | 0.00% | -66.7% |
Q1 2019 | $384,000 | -10.9% | 29,864 | -34.2% | 0.01% | -25.0% |
Q4 2018 | $431,000 | -12.4% | 45,413 | +48.1% | 0.01% | 0.0% |
Q2 2018 | $492,000 | +154.9% | 30,656 | +148.0% | 0.01% | +166.7% |
Q4 2017 | $193,000 | +20.6% | 12,360 | -33.9% | 0.00% | 0.0% |
Q1 2017 | $160,000 | -40.1% | 18,700 | -25.1% | 0.00% | -40.0% |
Q4 2016 | $267,000 | -51.9% | 24,954 | -51.3% | 0.01% | -50.0% |
Q3 2016 | $555,000 | +46.8% | 51,243 | -8.3% | 0.01% | +25.0% |
Q2 2016 | $378,000 | +62.9% | 55,854 | +12.0% | 0.01% | +60.0% |
Q1 2016 | $232,000 | +46.8% | 49,860 | +272.1% | 0.01% | +66.7% |
Q2 2015 | $158,000 | – | 13,400 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Lyon Street Capital, LLC | 1,471,518 | $23,618,000 | 8.40% |
INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 492,930 | $7,862,000 | 3.02% |
Consonance Capital Management LP | 2,747,198 | $44,093,000 | 2.84% |
NEXTHERA CAPITAL LP | 559,517 | $8,980,000 | 1.39% |
Eventide Asset Management | 1,086,400 | $17,437,000 | 0.72% |
Virtus ETF Advisers LLC | 45,850 | $736,000 | 0.65% |
KNOTT DAVID M | 90,000 | $1,445,000 | 0.54% |
Polar Capital LLP | 1,912,605 | $30,697,000 | 0.18% |
Artal Group S.A. | 400,000 | $6,420,000 | 0.14% |
J. Goldman & Co LP | 100,000 | $1,605,000 | 0.08% |